Quick Answer
Phathom Pharmaceuticals, Inc. reported Total Revenue of $175.11 million for the year ending 2025.
- Phathom Pharmaceuticals, Inc. showed an increase of +216.9% in Total Revenue from 2024 to 2025.
- This data is from Phathom Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: $0.00 | Q2 2023: $0.00 | Q3 2023: $0.00 | Q1 2024: $1.91 million | Q2 2024: $7.32 million | Q3 2024: $16.35 million | Q1 2025: $28.52 million | Q2 2025: $39.50 million | Q3 2025: $49.50 million.
- Historical annual values: Fiscal year 2025: $175.11 million | Fiscal year 2024: $55.25 million | Fiscal year 2023: $682.0 thousand | Fiscal year 2022: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: